• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯里西啶生物碱及其 N-氧化物毒性的动力学作用作为关键决定因素。

The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.

机构信息

Division of Toxicology, Wageningen University and Research, The Netherlands.

Department of Food Science and Human Nutrition, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah, Saudi Arabia.

出版信息

Planta Med. 2022 Feb;88(2):130-143. doi: 10.1055/a-1582-9794. Epub 2021 Nov 5.

DOI:10.1055/a-1582-9794
PMID:34741297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8807025/
Abstract

Pyrrolizidine alkaloids (PAs) are a large group of plant constituents of which especially the 1,2- unsaturated PAs raise a concern because of their liver toxicity and potential genotoxic carcinogenicity. This toxicity of PAs depends on their kinetics. Differences in absorption, distribution, metabolism, and excretion (ADME) characteristics of PAs may substantially alter the relative toxicity of PAs. As a result, kinetics will also affect relative potency (REP) values. The present review summarizes the current state-of-the art on PA kinetics and resulting consequences for toxicity and illustrates how physiologically-based kinetic (PBK) modelling can be applied to take kinetics into account when defining the relative differences in toxicity between PAs in the situation. We conclude that toxicokinetics play an important role in the overall toxicity of pyrrolizidine alkaloids. and that kinetics should therefore be considered when defining REP values for combined risk assessment. New approach methodologies (NAMs) can be of use to quantify these kinetic differences between PAs and their N-oxides, thus contributing to the 3Rs (Replacement, Reduction and Refinement) in animal studies.

摘要

吡咯里西啶生物碱(PAs)是一大类植物成分,其中特别是 1,2-不饱和 PAs 因其肝毒性和潜在的遗传毒性致癌性而引起关注。这些 PAs 的毒性取决于它们的动力学。PAs 的吸收、分布、代谢和排泄(ADME)特征的差异可能会极大地改变 PAs 的相对毒性。因此,动力学也会影响相对效力(REP)值。本综述总结了 PA 动力学的最新进展及其对毒性的影响,并说明了如何在定义 PA 毒性的相对差异时,应用基于生理学的动力学(PBK)模型来考虑动力学因素。我们的结论是,毒代动力学在吡咯里西啶生物碱的整体毒性中起着重要作用,因此在定义联合风险评估的 REP 值时应考虑动力学因素。新方法方法(NAMs)可用于量化 PA 及其 N-氧化物之间的这些动力学差异,从而有助于动物研究中的 3R(替代、减少和优化)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/5e181a1a0f77/10-1055-a-1582-9794-if0378pm06ab.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/04afb5f9f0a4/10-1055-a-1582-9794-if0378pm01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/eb0702d1e949/10-1055-a-1582-9794-if0378pm02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/dfe3c031c603/10-1055-a-1582-9794-if0378pm03ab.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/dd9e0ef29935/10-1055-a-1582-9794-if0378pm04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/d5d9e4e484c5/10-1055-a-1582-9794-if0378pm05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/5e181a1a0f77/10-1055-a-1582-9794-if0378pm06ab.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/04afb5f9f0a4/10-1055-a-1582-9794-if0378pm01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/eb0702d1e949/10-1055-a-1582-9794-if0378pm02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/dfe3c031c603/10-1055-a-1582-9794-if0378pm03ab.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/dd9e0ef29935/10-1055-a-1582-9794-if0378pm04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/d5d9e4e484c5/10-1055-a-1582-9794-if0378pm05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a8/8807025/5e181a1a0f77/10-1055-a-1582-9794-if0378pm06ab.jpg

相似文献

1
The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.吡咯里西啶生物碱及其 N-氧化物毒性的动力学作用作为关键决定因素。
Planta Med. 2022 Feb;88(2):130-143. doi: 10.1055/a-1582-9794. Epub 2021 Nov 5.
2
Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.基于生理学的动力学模型预测,与 riddelliine 相比, riddelliine N-氧化物在大鼠体内的相对效力与剂量有关。
Arch Toxicol. 2022 Jan;96(1):135-151. doi: 10.1007/s00204-021-03179-w. Epub 2021 Oct 20.
3
Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives.吡咯里西啶生物碱毒性和风险评估中的毒代动力学和替代测试策略的作用;现状和未来展望。
Food Chem Toxicol. 2019 Sep;131:110572. doi: 10.1016/j.fct.2019.110572. Epub 2019 Jun 8.
4
The toxicokinetic and metabolism of structurally diverse pyrrolizidine alkaloids in rats.结构多样的吡咯里西啶生物碱在大鼠体内的毒代动力学和代谢。
J Ethnopharmacol. 2024 Mar 1;321:117390. doi: 10.1016/j.jep.2023.117390. Epub 2023 Nov 11.
5
Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.吡咯里西啶生物碱 N-氧化物在肠道和肝脏中的生物转化为有毒的吡咯里西啶生物碱。
Arch Toxicol. 2019 Aug;93(8):2197-2209. doi: 10.1007/s00204-019-02499-2. Epub 2019 Jun 20.
6
Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.肝毒性吡咯里西啶生物碱及其 N-氧化物的吸收差异-机制及其潜在的毒性影响。
J Ethnopharmacol. 2020 Mar 1;249:112421. doi: 10.1016/j.jep.2019.112421. Epub 2019 Nov 20.
7
Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells.用 HepaRG 人肝细胞微核试验测定的十五种吡咯里西啶生物碱诱导 DNA 损伤的相对效力。
Food Chem Toxicol. 2018 Nov;121:72-81. doi: 10.1016/j.fct.2018.08.003. Epub 2018 Aug 17.
8
Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines.用于食品和草药中吡咯里西啶生物碱毒理学风险评估的临时相对效力因子。
Toxicol Lett. 2016 Nov 30;263:44-57. doi: 10.1016/j.toxlet.2016.05.002. Epub 2016 May 6.
9
Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.吡咯里西啶生物碱的代谢介导的细胞毒性和遗传毒性。
Arch Toxicol. 2021 Jun;95(6):1917-1942. doi: 10.1007/s00204-021-03060-w. Epub 2021 May 18.
10
Risk Assessment of (Herbal) Teas Containing Pyrrolizidine Alkaloids (PAs) Based on Margin of Exposure Approach and Relative Potency (REP) Factors.基于暴露边际法和相对效力(REP)因子对含吡咯里西啶生物碱(PAs)的(草本)茶进行风险评估。
Foods. 2022 Sep 21;11(19):2946. doi: 10.3390/foods11192946.

引用本文的文献

1
Characterization of Lipophilicity and Blood Partitioning of Pyrrolizidine Alkaloids and Their N-Oxides In Vitro and In Silico for Toxicokinetic Modeling.用于毒代动力学建模的吡咯里西啶生物碱及其N-氧化物的亲脂性和血液分配的体外和计算机模拟表征
Planta Med. 2025 Apr;91(5):274-282. doi: 10.1055/a-2523-3987. Epub 2025 Jan 23.
2
Exploring tea and herbal infusions consumption patterns and behaviours: The case of Portuguese consumers.探索茶和草本浸剂的消费模式与行为:以葡萄牙消费者为例。
Heliyon. 2024 Mar 27;10(7):e28779. doi: 10.1016/j.heliyon.2024.e28779. eCollection 2024 Apr 15.

本文引用的文献

1
LC-MS/MS method for determination of seneciphylline and its metabolite, seneciphylline N-oxide in rat plasma, and its application to a rat pharmacokinetic study.LC-MS/MS 法测定大鼠血浆中的西贝碱及其代谢物西贝碱 N-氧化物及其在大鼠药代动力学研究中的应用。
Biomed Chromatogr. 2021 Sep;35(9):e5145. doi: 10.1002/bmc.5145. Epub 2021 May 8.
2
Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.将 OCT2 转运体的肾排泄纳入生理基于动力学模型,以预测替米巴肽在大鼠体内的动力学。
Toxicol Lett. 2021 Jun 1;343:34-43. doi: 10.1016/j.toxlet.2021.02.013. Epub 2021 Feb 24.
3
Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies.
开发一个基于网络的工具箱,以支持非动物测试策略中的定量体外到体内外推(QIVIVE)。
Chem Res Toxicol. 2021 Feb 15;34(2):460-472. doi: 10.1021/acs.chemrestox.0c00307. Epub 2020 Dec 31.
4
Protein cross-linking in primary cultured mouse hepatocytes by dehydropyrrolizidine alkaloids: Structure-toxicity relationship.原发性培养的小鼠肝细胞中脱水吡咯里西啶生物碱的蛋白质交联:结构-毒性关系。
Toxicon. 2020 Oct 30;186:4-11. doi: 10.1016/j.toxicon.2020.07.015. Epub 2020 Jul 17.
5
Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements.蜂蜜、茶、草药浸液和食品补充剂中存在吡咯里西啶生物碱对人体健康的风险。
EFSA J. 2017 Jul 27;15(7):e04908. doi: 10.2903/j.efsa.2017.4908. eCollection 2017 Jul.
6
Update: use of the benchmark dose approach in risk assessment.更新:基准剂量法在风险评估中的应用。
EFSA J. 2017 Jan 24;15(1):e04658. doi: 10.2903/j.efsa.2017.4658. eCollection 2017 Jan.
7
Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.基于体外生理的联合动力学建模方法预测野百合碱诱导的大鼠肝毒性。
Arch Toxicol. 2020 Sep;94(9):3281-3295. doi: 10.1007/s00204-020-02798-z. Epub 2020 Jun 9.
8
Pyrrolizidine alkaloids in food and phytomedicine: Occurrence, exposure, toxicity, mechanisms, and risk assessment - A review.食品和植物药中的吡咯里西啶生物碱:发生、暴露、毒性、机制和风险评估-综述。
Food Chem Toxicol. 2020 Feb;136:111107. doi: 10.1016/j.fct.2019.111107. Epub 2020 Jan 3.
9
Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.肝毒性吡咯里西啶生物碱及其 N-氧化物的吸收差异-机制及其潜在的毒性影响。
J Ethnopharmacol. 2020 Mar 1;249:112421. doi: 10.1016/j.jep.2019.112421. Epub 2019 Nov 20.
10
Structure-dependent hepato-cytotoxic potencies of selected pyrrolizidine alkaloids in primary rat hepatocyte culture.在原代大鼠肝细胞培养物中,选定的吡咯里西啶生物碱的结构依赖性肝毒性效力。
Food Chem Toxicol. 2020 Jan;135:110923. doi: 10.1016/j.fct.2019.110923. Epub 2019 Oct 28.